Use of Combined Measurements of Serum Infliximab and Anti-Infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 10 Nov 2015
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 24 Nov 2011 Additional lead trial centres identified as reported by ClinicalTrials.gov.
- 24 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Nov 2010 Additional lead trial investigators identified as reported by ClinicalTrials.gov.